Himadri Speciality Chemical Reports Robust H1 FY27 Results: Revenue Surges 43% to ₹3,123 Cr
Himadri Speciality Chemical reported robust H1 FY27 results with revenue at ₹3,123 Cr (+43% YoY) and PAT at ₹460 Cr (+29% YoY). Q2 FY27 saw EBITDA grow 57.93% to ₹1,691 Cr. CMD & CEO Anurag Choudhary expressed satisfaction with performance milestones. Strategic developments include the proposed Birla Tyres merger and Sicona's acquisition of Advano.
The significant financial growth, strategic mergers, and investments in advanced technologies like battery materials indicate a substantial positive impact on the company's future prospects and market position.
The company has reported strong year-on-year growth in revenue, EBITDA, and Profit After Tax for both the quarter and half-year ended September 30, 2026. The management commentary is positive, highlighting strategic achievements and future potential.
Himadri Speciality Chemical Ltd. has announced its financial results for the quarter and half-year ended September 30, 2026. The company reported a significant year-on-year growth in its consolidated financials.
For the second quarter of FY27, revenue from operations increased by 27.48% compared to Q2 FY26, while Profit After Tax (PAT) saw a rise of 31.33%. EBITDA for the quarter also grew by a substantial 57.93%, reaching ₹1,691 crore from ₹1,071 crore in Q2 FY26.
The first half of FY27 (H1FY27) demonstrated strong performance with revenue from operations at ₹3,123 crore, marking a 43% increase year-on-year. EBITDA for H1FY27 stood at ₹616 crore, up 30% YoY, and Profit After Tax was ₹460 crore, a 29% increase YoY.
Mr. Anurag Choudhary, CMD & CEO of Himadri Speciality Chemical Ltd., commented on the results, stating, "We are pleased to report another robust quarter, achieving new performance milestones with consolidated H1 FY27 revenue surpassing ₹3,000 crore, EBITDA exceeding ₹600 crore, and PAT exceeding ₹450 crore. These achievements establish a new benchmark for Himadri and reflect the strength of our strategy, disciplined execution and continued focus on higher-value products."
He further elaborated on the drivers of profitability, including an optimized product mix, growth in core businesses, and an expanding portfolio of specialty and advanced materials. Investments in R&D, innovation, customer relationships, and strategic global partnerships have enabled revenue diversification and strengthened the company's competitive position.
The company also highlighted strategic developments during the quarter, including the proposed merger of Birla Tyres business with Himadri, aimed at creating an integrated tyre value chain. Furthermore, Himadri strengthened its investment in Sicona Battery Technologies, which completed the acquisition of Advano (USA) and secured AUD 45 million in funding from ARENA for its silicon anode technology. The strategic investment in International Battery Company (IBC) positions Himadri in the lithium-ion value chain, facilitating material validation, cell development, and commercial deployment.
What to do with a filing like this
Himadri Speciality Chemical Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Himadri Speciality Chemical Limited. Read the original for the full detail.